nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—hypertension—type 2 diabetes mellitus	0.43	1	CtDrD
Amiloride—SLC9A1—type 2 diabetes mellitus	0.357	1	CbGaD
Amiloride—ASIC2—peripheral nervous system—type 2 diabetes mellitus	0.00555	0.131	CbGeAlD
Amiloride—ASIC2—nerve—type 2 diabetes mellitus	0.00433	0.102	CbGeAlD
Amiloride—PLAU—endothelium—type 2 diabetes mellitus	0.00212	0.0498	CbGeAlD
Amiloride—PLAU—islet of Langerhans—type 2 diabetes mellitus	0.0012	0.0284	CbGeAlD
Amiloride—AOC1—nephron tubule—type 2 diabetes mellitus	0.00107	0.0251	CbGeAlD
Amiloride—SCNN1A—islet of Langerhans—type 2 diabetes mellitus	0.00105	0.0248	CbGeAlD
Amiloride—SLC9A1—nephron tubule—type 2 diabetes mellitus	0.00102	0.0241	CbGeAlD
Amiloride—PLAU—nephron tubule—type 2 diabetes mellitus	0.000969	0.0228	CbGeAlD
Amiloride—SCNN1G—kidney—type 2 diabetes mellitus	0.000956	0.0225	CbGeAlD
Amiloride—AOC1—kidney—type 2 diabetes mellitus	0.000938	0.0221	CbGeAlD
Amiloride—SCNN1G—cortex of kidney—type 2 diabetes mellitus	0.000931	0.0219	CbGeAlD
Amiloride—SLC9A1—cardiovascular system—type 2 diabetes mellitus	0.000918	0.0216	CbGeAlD
Amiloride—AOC1—cortex of kidney—type 2 diabetes mellitus	0.000914	0.0215	CbGeAlD
Amiloride—SLC9A1—kidney—type 2 diabetes mellitus	0.000899	0.0212	CbGeAlD
Amiloride—SLC9A1—pancreas—type 2 diabetes mellitus	0.000893	0.021	CbGeAlD
Amiloride—SLC9A1—cortex of kidney—type 2 diabetes mellitus	0.000875	0.0206	CbGeAlD
Amiloride—PLAU—cardiovascular system—type 2 diabetes mellitus	0.000871	0.0205	CbGeAlD
Amiloride—PLAU—kidney—type 2 diabetes mellitus	0.000852	0.0201	CbGeAlD
Amiloride—SCNN1A—nephron tubule—type 2 diabetes mellitus	0.000849	0.02	CbGeAlD
Amiloride—PLAU—pancreas—type 2 diabetes mellitus	0.000846	0.0199	CbGeAlD
Amiloride—ASIC1—adipose tissue—type 2 diabetes mellitus	0.000846	0.0199	CbGeAlD
Amiloride—PLAU—cortex of kidney—type 2 diabetes mellitus	0.00083	0.0195	CbGeAlD
Amiloride—SLC9A1—adipose tissue—type 2 diabetes mellitus	0.00081	0.0191	CbGeAlD
Amiloride—SCNN1B—kidney—type 2 diabetes mellitus	0.000808	0.019	CbGeAlD
Amiloride—SCNN1B—cortex of kidney—type 2 diabetes mellitus	0.000787	0.0185	CbGeAlD
Amiloride—PLAU—adipose tissue—type 2 diabetes mellitus	0.000768	0.0181	CbGeAlD
Amiloride—SCNN1A—kidney—type 2 diabetes mellitus	0.000746	0.0176	CbGeAlD
Amiloride—SCNN1A—pancreas—type 2 diabetes mellitus	0.000741	0.0175	CbGeAlD
Amiloride—SCNN1B—adipose tissue—type 2 diabetes mellitus	0.000728	0.0171	CbGeAlD
Amiloride—SCNN1A—cortex of kidney—type 2 diabetes mellitus	0.000727	0.0171	CbGeAlD
Amiloride—SCNN1A—adipose tissue—type 2 diabetes mellitus	0.000672	0.0158	CbGeAlD
Amiloride—SCNN1D—liver—type 2 diabetes mellitus	0.000604	0.0142	CbGeAlD
Amiloride—AOC1—liver—type 2 diabetes mellitus	0.000593	0.014	CbGeAlD
Amiloride—SLC9A1—liver—type 2 diabetes mellitus	0.000568	0.0134	CbGeAlD
Amiloride—PLAU—liver—type 2 diabetes mellitus	0.000538	0.0127	CbGeAlD
Amiloride—SCNN1A—liver—type 2 diabetes mellitus	0.000472	0.0111	CbGeAlD
Amiloride—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000458	0.0108	CbGeAlD
Amiloride—SLC22A2—kidney—type 2 diabetes mellitus	0.000403	0.00949	CbGeAlD
Amiloride—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000392	0.00924	CbGeAlD
Amiloride—SLC22A4—nephron tubule—type 2 diabetes mellitus	0.00034	0.00801	CbGeAlD
Amiloride—SLC22A4—kidney—type 2 diabetes mellitus	0.000299	0.00704	CbGeAlD
Amiloride—SLC22A4—cortex of kidney—type 2 diabetes mellitus	0.000291	0.00685	CbGeAlD
Amiloride—SLC22A1—kidney—type 2 diabetes mellitus	0.000285	0.0067	CbGeAlD
Amiloride—SLC22A4—adipose tissue—type 2 diabetes mellitus	0.000269	0.00634	CbGeAlD
Amiloride—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000257	0.00604	CbGeAlD
Amiloride—SLC22A1—liver—type 2 diabetes mellitus	0.00018	0.00424	CbGeAlD
Amiloride—Cough—Orlistat—type 2 diabetes mellitus	8.61e-05	0.000884	CcSEcCtD
Amiloride—Asthenia—Glimepiride—type 2 diabetes mellitus	8.6e-05	0.000882	CcSEcCtD
Amiloride—Decreased appetite—Glyburide—type 2 diabetes mellitus	8.59e-05	0.000881	CcSEcCtD
Amiloride—Asthenia—Sitagliptin—type 2 diabetes mellitus	8.57e-05	0.000879	CcSEcCtD
Amiloride—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	8.55e-05	0.000877	CcSEcCtD
Amiloride—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	8.53e-05	0.000875	CcSEcCtD
Amiloride—Tremor—Metformin—type 2 diabetes mellitus	8.52e-05	0.000874	CcSEcCtD
Amiloride—Arthralgia—Valsartan—type 2 diabetes mellitus	8.51e-05	0.000872	CcSEcCtD
Amiloride—Chest pain—Valsartan—type 2 diabetes mellitus	8.51e-05	0.000872	CcSEcCtD
Amiloride—Dizziness—Glipizide—type 2 diabetes mellitus	8.49e-05	0.000871	CcSEcCtD
Amiloride—Pruritus—Glimepiride—type 2 diabetes mellitus	8.48e-05	0.00087	CcSEcCtD
Amiloride—Flatulence—Irbesartan—type 2 diabetes mellitus	8.46e-05	0.000868	CcSEcCtD
Amiloride—Tension—Irbesartan—type 2 diabetes mellitus	8.42e-05	0.000864	CcSEcCtD
Amiloride—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	8.42e-05	0.000863	CcSEcCtD
Amiloride—Chest pain—Orlistat—type 2 diabetes mellitus	8.4e-05	0.000862	CcSEcCtD
Amiloride—Nervousness—Irbesartan—type 2 diabetes mellitus	8.34e-05	0.000855	CcSEcCtD
Amiloride—Muscle spasms—Irbesartan—type 2 diabetes mellitus	8.25e-05	0.000847	CcSEcCtD
Amiloride—Alopecia—Losartan—type 2 diabetes mellitus	8.2e-05	0.000841	CcSEcCtD
Amiloride—Diarrhoea—Glimepiride—type 2 diabetes mellitus	8.2e-05	0.000841	CcSEcCtD
Amiloride—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	8.17e-05	0.000838	CcSEcCtD
Amiloride—Vomiting—Glipizide—type 2 diabetes mellitus	8.16e-05	0.000837	CcSEcCtD
Amiloride—Feeling abnormal—Glyburide—type 2 diabetes mellitus	8.14e-05	0.000835	CcSEcCtD
Amiloride—Dizziness—Pioglitazone—type 2 diabetes mellitus	8.14e-05	0.000834	CcSEcCtD
Amiloride—Rash—Glipizide—type 2 diabetes mellitus	8.1e-05	0.00083	CcSEcCtD
Amiloride—Dermatitis—Glipizide—type 2 diabetes mellitus	8.09e-05	0.00083	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	8.09e-05	0.000829	CcSEcCtD
Amiloride—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	8.08e-05	0.000829	CcSEcCtD
Amiloride—Headache—Glipizide—type 2 diabetes mellitus	8.04e-05	0.000825	CcSEcCtD
Amiloride—Tremor—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000825	CcSEcCtD
Amiloride—Palpitations—Metformin—type 2 diabetes mellitus	8.04e-05	0.000825	CcSEcCtD
Amiloride—Insomnia—Gliclazide—type 2 diabetes mellitus	8.03e-05	0.000823	CcSEcCtD
Amiloride—Shock—Valsartan—type 2 diabetes mellitus	8.02e-05	0.000823	CcSEcCtD
Amiloride—Paraesthesia—Gliclazide—type 2 diabetes mellitus	7.97e-05	0.000817	CcSEcCtD
Amiloride—Flatulence—Losartan—type 2 diabetes mellitus	7.96e-05	0.000817	CcSEcCtD
Amiloride—Tension—Losartan—type 2 diabetes mellitus	7.93e-05	0.000813	CcSEcCtD
Amiloride—Dizziness—Glimepiride—type 2 diabetes mellitus	7.92e-05	0.000813	CcSEcCtD
Amiloride—Dyspnoea—Gliclazide—type 2 diabetes mellitus	7.91e-05	0.000811	CcSEcCtD
Amiloride—Dizziness—Sitagliptin—type 2 diabetes mellitus	7.9e-05	0.00081	CcSEcCtD
Amiloride—Somnolence—Gliclazide—type 2 diabetes mellitus	7.89e-05	0.000809	CcSEcCtD
Amiloride—Nervousness—Losartan—type 2 diabetes mellitus	7.85e-05	0.000805	CcSEcCtD
Amiloride—Back pain—Losartan—type 2 diabetes mellitus	7.82e-05	0.000802	CcSEcCtD
Amiloride—Abdominal pain—Glyburide—type 2 diabetes mellitus	7.81e-05	0.000801	CcSEcCtD
Amiloride—Dyspepsia—Gliclazide—type 2 diabetes mellitus	7.81e-05	0.000801	CcSEcCtD
Amiloride—Anorexia—Valsartan—type 2 diabetes mellitus	7.77e-05	0.000797	CcSEcCtD
Amiloride—Muscle spasms—Losartan—type 2 diabetes mellitus	7.77e-05	0.000797	CcSEcCtD
Amiloride—Asthenia—Bromocriptine—type 2 diabetes mellitus	7.76e-05	0.000796	CcSEcCtD
Amiloride—Chest pain—Metformin—type 2 diabetes mellitus	7.75e-05	0.000794	CcSEcCtD
Amiloride—Vertigo—Irbesartan—type 2 diabetes mellitus	7.71e-05	0.000791	CcSEcCtD
Amiloride—Headache—Pioglitazone—type 2 diabetes mellitus	7.71e-05	0.00079	CcSEcCtD
Amiloride—Visual impairment—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000787	CcSEcCtD
Amiloride—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	7.66e-05	0.000786	CcSEcCtD
Amiloride—Fatigue—Gliclazide—type 2 diabetes mellitus	7.65e-05	0.000785	CcSEcCtD
Amiloride—Nausea—Glipizide—type 2 diabetes mellitus	7.63e-05	0.000782	CcSEcCtD
Amiloride—Vomiting—Glimepiride—type 2 diabetes mellitus	7.62e-05	0.000782	CcSEcCtD
Amiloride—Vomiting—Sitagliptin—type 2 diabetes mellitus	7.6e-05	0.000779	CcSEcCtD
Amiloride—Pain—Gliclazide—type 2 diabetes mellitus	7.59e-05	0.000778	CcSEcCtD
Amiloride—Constipation—Gliclazide—type 2 diabetes mellitus	7.59e-05	0.000778	CcSEcCtD
Amiloride—Tremor—Losartan—type 2 diabetes mellitus	7.57e-05	0.000776	CcSEcCtD
Amiloride—Rash—Glimepiride—type 2 diabetes mellitus	7.56e-05	0.000775	CcSEcCtD
Amiloride—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.55e-05	0.000774	CcSEcCtD
Amiloride—Rash—Sitagliptin—type 2 diabetes mellitus	7.53e-05	0.000773	CcSEcCtD
Amiloride—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.53e-05	0.000772	CcSEcCtD
Amiloride—Headache—Glimepiride—type 2 diabetes mellitus	7.51e-05	0.00077	CcSEcCtD
Amiloride—Cough—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000768	CcSEcCtD
Amiloride—Headache—Sitagliptin—type 2 diabetes mellitus	7.48e-05	0.000768	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.43e-05	0.000762	CcSEcCtD
Amiloride—Tinnitus—Ramipril—type 2 diabetes mellitus	7.42e-05	0.000761	CcSEcCtD
Amiloride—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.4e-05	0.000759	CcSEcCtD
Amiloride—Insomnia—Valsartan—type 2 diabetes mellitus	7.37e-05	0.000756	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.34e-05	0.000753	CcSEcCtD
Amiloride—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.32e-05	0.000751	CcSEcCtD
Amiloride—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.31e-05	0.00075	CcSEcCtD
Amiloride—Chest pain—Irbesartan—type 2 diabetes mellitus	7.31e-05	0.00075	CcSEcCtD
Amiloride—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.31e-05	0.00075	CcSEcCtD
Amiloride—Shock—Metformin—type 2 diabetes mellitus	7.3e-05	0.000749	CcSEcCtD
Amiloride—Insomnia—Orlistat—type 2 diabetes mellitus	7.29e-05	0.000747	CcSEcCtD
Amiloride—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.27e-05	0.000746	CcSEcCtD
Amiloride—Vertigo—Losartan—type 2 diabetes mellitus	7.26e-05	0.000745	CcSEcCtD
Amiloride—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.26e-05	0.000744	CcSEcCtD
Amiloride—Somnolence—Valsartan—type 2 diabetes mellitus	7.25e-05	0.000743	CcSEcCtD
Amiloride—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.23e-05	0.000742	CcSEcCtD
Amiloride—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.18e-05	0.000736	CcSEcCtD
Amiloride—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.15e-05	0.000733	CcSEcCtD
Amiloride—Palpitations—Losartan—type 2 diabetes mellitus	7.14e-05	0.000732	CcSEcCtD
Amiloride—Nausea—Glimepiride—type 2 diabetes mellitus	7.12e-05	0.00073	CcSEcCtD
Amiloride—Nausea—Sitagliptin—type 2 diabetes mellitus	7.1e-05	0.000728	CcSEcCtD
Amiloride—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.09e-05	0.000727	CcSEcCtD
Amiloride—Asthenia—Glyburide—type 2 diabetes mellitus	7.09e-05	0.000727	CcSEcCtD
Amiloride—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.09e-05	0.000727	CcSEcCtD
Amiloride—Anorexia—Metformin—type 2 diabetes mellitus	7.08e-05	0.000726	CcSEcCtD
Amiloride—Cough—Losartan—type 2 diabetes mellitus	7.05e-05	0.000723	CcSEcCtD
Amiloride—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.04e-05	0.000722	CcSEcCtD
Amiloride—Alopecia—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000721	CcSEcCtD
Amiloride—Fatigue—Valsartan—type 2 diabetes mellitus	7.03e-05	0.000721	CcSEcCtD
Amiloride—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.02e-05	0.00072	CcSEcCtD
Amiloride—Decreased appetite—Orlistat—type 2 diabetes mellitus	7e-05	0.000718	CcSEcCtD
Amiloride—Pruritus—Glyburide—type 2 diabetes mellitus	6.99e-05	0.000717	CcSEcCtD
Amiloride—Constipation—Valsartan—type 2 diabetes mellitus	6.97e-05	0.000715	CcSEcCtD
Amiloride—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.96e-05	0.000713	CcSEcCtD
Amiloride—Fatigue—Orlistat—type 2 diabetes mellitus	6.95e-05	0.000712	CcSEcCtD
Amiloride—Shock—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.000707	CcSEcCtD
Amiloride—Pain—Orlistat—type 2 diabetes mellitus	6.89e-05	0.000707	CcSEcCtD
Amiloride—Chest pain—Losartan—type 2 diabetes mellitus	6.88e-05	0.000706	CcSEcCtD
Amiloride—Arthralgia—Losartan—type 2 diabetes mellitus	6.88e-05	0.000706	CcSEcCtD
Amiloride—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.87e-05	0.000705	CcSEcCtD
Amiloride—Rash—Bromocriptine—type 2 diabetes mellitus	6.82e-05	0.000699	CcSEcCtD
Amiloride—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.81e-05	0.000699	CcSEcCtD
Amiloride—Tension—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000697	CcSEcCtD
Amiloride—Headache—Bromocriptine—type 2 diabetes mellitus	6.77e-05	0.000695	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.76e-05	0.000694	CcSEcCtD
Amiloride—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.76e-05	0.000694	CcSEcCtD
Amiloride—Nervousness—Ramipril—type 2 diabetes mellitus	6.73e-05	0.00069	CcSEcCtD
Amiloride—Anorexia—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000685	CcSEcCtD
Amiloride—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.67e-05	0.000684	CcSEcCtD
Amiloride—Paraesthesia—Metformin—type 2 diabetes mellitus	6.67e-05	0.000684	CcSEcCtD
Amiloride—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.66e-05	0.000683	CcSEcCtD
Amiloride—Confusional state—Losartan—type 2 diabetes mellitus	6.65e-05	0.000682	CcSEcCtD
Amiloride—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.64e-05	0.000681	CcSEcCtD
Amiloride—Dyspnoea—Metformin—type 2 diabetes mellitus	6.62e-05	0.000679	CcSEcCtD
Amiloride—Somnolence—Metformin—type 2 diabetes mellitus	6.6e-05	0.000677	CcSEcCtD
Amiloride—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.59e-05	0.000676	CcSEcCtD
Amiloride—Dyspepsia—Metformin—type 2 diabetes mellitus	6.54e-05	0.00067	CcSEcCtD
Amiloride—Tremor—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000666	CcSEcCtD
Amiloride—Shock—Losartan—type 2 diabetes mellitus	6.49e-05	0.000665	CcSEcCtD
Amiloride—Decreased appetite—Metformin—type 2 diabetes mellitus	6.45e-05	0.000662	CcSEcCtD
Amiloride—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.45e-05	0.000661	CcSEcCtD
Amiloride—Nausea—Bromocriptine—type 2 diabetes mellitus	6.42e-05	0.000659	CcSEcCtD
Amiloride—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.41e-05	0.000657	CcSEcCtD
Amiloride—Fatigue—Metformin—type 2 diabetes mellitus	6.4e-05	0.000657	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000655	CcSEcCtD
Amiloride—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.37e-05	0.000653	CcSEcCtD
Amiloride—Asthenia—Gliclazide—type 2 diabetes mellitus	6.37e-05	0.000653	CcSEcCtD
Amiloride—Constipation—Metformin—type 2 diabetes mellitus	6.35e-05	0.000651	CcSEcCtD
Amiloride—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.29e-05	0.000645	CcSEcCtD
Amiloride—Anorexia—Losartan—type 2 diabetes mellitus	6.29e-05	0.000645	CcSEcCtD
Amiloride—Vomiting—Glyburide—type 2 diabetes mellitus	6.28e-05	0.000645	CcSEcCtD
Amiloride—Pruritus—Gliclazide—type 2 diabetes mellitus	6.28e-05	0.000644	CcSEcCtD
Amiloride—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000641	CcSEcCtD
Amiloride—Rash—Glyburide—type 2 diabetes mellitus	6.23e-05	0.000639	CcSEcCtD
Amiloride—Somnolence—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000639	CcSEcCtD
Amiloride—Dermatitis—Glyburide—type 2 diabetes mellitus	6.23e-05	0.000639	CcSEcCtD
Amiloride—Vertigo—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000638	CcSEcCtD
Amiloride—Headache—Glyburide—type 2 diabetes mellitus	6.19e-05	0.000635	CcSEcCtD
Amiloride—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000633	CcSEcCtD
Amiloride—Palpitations—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000628	CcSEcCtD
Amiloride—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.12e-05	0.000628	CcSEcCtD
Amiloride—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.000625	CcSEcCtD
Amiloride—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.07e-05	0.000623	CcSEcCtD
Amiloride—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.07e-05	0.000623	CcSEcCtD
Amiloride—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.05e-05	0.00062	CcSEcCtD
Amiloride—Cough—Ramipril—type 2 diabetes mellitus	6.05e-05	0.00062	CcSEcCtD
Amiloride—Fatigue—Irbesartan—type 2 diabetes mellitus	6.04e-05	0.00062	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.01e-05	0.000616	CcSEcCtD
Amiloride—Pain—Irbesartan—type 2 diabetes mellitus	5.99e-05	0.000615	CcSEcCtD
Amiloride—Constipation—Irbesartan—type 2 diabetes mellitus	5.99e-05	0.000615	CcSEcCtD
Amiloride—Insomnia—Losartan—type 2 diabetes mellitus	5.96e-05	0.000612	CcSEcCtD
Amiloride—Paraesthesia—Losartan—type 2 diabetes mellitus	5.92e-05	0.000607	CcSEcCtD
Amiloride—Chest pain—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000605	CcSEcCtD
Amiloride—Arthralgia—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000605	CcSEcCtD
Amiloride—Dyspnoea—Losartan—type 2 diabetes mellitus	5.88e-05	0.000603	CcSEcCtD
Amiloride—Nausea—Glyburide—type 2 diabetes mellitus	5.87e-05	0.000602	CcSEcCtD
Amiloride—Abdominal pain—Metformin—type 2 diabetes mellitus	5.87e-05	0.000602	CcSEcCtD
Amiloride—Dizziness—Gliclazide—type 2 diabetes mellitus	5.87e-05	0.000602	CcSEcCtD
Amiloride—Somnolence—Losartan—type 2 diabetes mellitus	5.86e-05	0.000601	CcSEcCtD
Amiloride—Asthenia—Valsartan—type 2 diabetes mellitus	5.85e-05	0.0006	CcSEcCtD
Amiloride—Dyspepsia—Losartan—type 2 diabetes mellitus	5.8e-05	0.000595	CcSEcCtD
Amiloride—Asthenia—Orlistat—type 2 diabetes mellitus	5.78e-05	0.000593	CcSEcCtD
Amiloride—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.77e-05	0.000592	CcSEcCtD
Amiloride—Pruritus—Valsartan—type 2 diabetes mellitus	5.77e-05	0.000592	CcSEcCtD
Amiloride—Decreased appetite—Losartan—type 2 diabetes mellitus	5.73e-05	0.000588	CcSEcCtD
Amiloride—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000588	CcSEcCtD
Amiloride—Confusional state—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000585	CcSEcCtD
Amiloride—Pruritus—Orlistat—type 2 diabetes mellitus	5.7e-05	0.000585	CcSEcCtD
Amiloride—Fatigue—Losartan—type 2 diabetes mellitus	5.69e-05	0.000583	CcSEcCtD
Amiloride—Vomiting—Gliclazide—type 2 diabetes mellitus	5.64e-05	0.000579	CcSEcCtD
Amiloride—Pain—Losartan—type 2 diabetes mellitus	5.64e-05	0.000578	CcSEcCtD
Amiloride—Constipation—Losartan—type 2 diabetes mellitus	5.64e-05	0.000578	CcSEcCtD
Amiloride—Rash—Gliclazide—type 2 diabetes mellitus	5.6e-05	0.000574	CcSEcCtD
Amiloride—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.59e-05	0.000573	CcSEcCtD
Amiloride—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.58e-05	0.000572	CcSEcCtD
Amiloride—Shock—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000571	CcSEcCtD
Amiloride—Headache—Gliclazide—type 2 diabetes mellitus	5.56e-05	0.00057	CcSEcCtD
Amiloride—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.54e-05	0.000568	CcSEcCtD
Amiloride—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.51e-05	0.000565	CcSEcCtD
Amiloride—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.43e-05	0.000557	CcSEcCtD
Amiloride—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.39e-05	0.000553	CcSEcCtD
Amiloride—Dizziness—Valsartan—type 2 diabetes mellitus	5.39e-05	0.000553	CcSEcCtD
Amiloride—Anorexia—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000553	CcSEcCtD
Amiloride—Dizziness—Orlistat—type 2 diabetes mellitus	5.33e-05	0.000546	CcSEcCtD
Amiloride—Asthenia—Metformin—type 2 diabetes mellitus	5.33e-05	0.000546	CcSEcCtD
Amiloride—Nausea—Gliclazide—type 2 diabetes mellitus	5.27e-05	0.000541	CcSEcCtD
Amiloride—Pruritus—Metformin—type 2 diabetes mellitus	5.25e-05	0.000539	CcSEcCtD
Amiloride—Abdominal pain—Losartan—type 2 diabetes mellitus	5.21e-05	0.000535	CcSEcCtD
Amiloride—Vomiting—Valsartan—type 2 diabetes mellitus	5.18e-05	0.000532	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000528	CcSEcCtD
Amiloride—Rash—Valsartan—type 2 diabetes mellitus	5.14e-05	0.000527	CcSEcCtD
Amiloride—Dermatitis—Valsartan—type 2 diabetes mellitus	5.14e-05	0.000527	CcSEcCtD
Amiloride—Vomiting—Orlistat—type 2 diabetes mellitus	5.12e-05	0.000525	CcSEcCtD
Amiloride—Insomnia—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000525	CcSEcCtD
Amiloride—Headache—Valsartan—type 2 diabetes mellitus	5.11e-05	0.000524	CcSEcCtD
Amiloride—Diarrhoea—Metformin—type 2 diabetes mellitus	5.08e-05	0.000521	CcSEcCtD
Amiloride—Rash—Orlistat—type 2 diabetes mellitus	5.08e-05	0.000521	CcSEcCtD
Amiloride—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000521	CcSEcCtD
Amiloride—Dermatitis—Orlistat—type 2 diabetes mellitus	5.08e-05	0.000521	CcSEcCtD
Amiloride—Headache—Orlistat—type 2 diabetes mellitus	5.05e-05	0.000518	CcSEcCtD
Amiloride—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000517	CcSEcCtD
Amiloride—Asthenia—Irbesartan—type 2 diabetes mellitus	5.03e-05	0.000516	CcSEcCtD
Amiloride—Somnolence—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000516	CcSEcCtD
Amiloride—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.98e-05	0.00051	CcSEcCtD
Amiloride—Pruritus—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000508	CcSEcCtD
Amiloride—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000504	CcSEcCtD
Amiloride—Dizziness—Metformin—type 2 diabetes mellitus	4.91e-05	0.000504	CcSEcCtD
Amiloride—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000501	CcSEcCtD
Amiloride—Fatigue—Ramipril—type 2 diabetes mellitus	4.87e-05	0.0005	CcSEcCtD
Amiloride—Nausea—Valsartan—type 2 diabetes mellitus	4.84e-05	0.000497	CcSEcCtD
Amiloride—Constipation—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000496	CcSEcCtD
Amiloride—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.79e-05	0.000492	CcSEcCtD
Amiloride—Nausea—Orlistat—type 2 diabetes mellitus	4.79e-05	0.000491	CcSEcCtD
Amiloride—Asthenia—Losartan—type 2 diabetes mellitus	4.73e-05	0.000485	CcSEcCtD
Amiloride—Vomiting—Metformin—type 2 diabetes mellitus	4.72e-05	0.000484	CcSEcCtD
Amiloride—Rash—Metformin—type 2 diabetes mellitus	4.68e-05	0.00048	CcSEcCtD
Amiloride—Dermatitis—Metformin—type 2 diabetes mellitus	4.68e-05	0.00048	CcSEcCtD
Amiloride—Pruritus—Losartan—type 2 diabetes mellitus	4.67e-05	0.000479	CcSEcCtD
Amiloride—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000478	CcSEcCtD
Amiloride—Headache—Metformin—type 2 diabetes mellitus	4.65e-05	0.000477	CcSEcCtD
Amiloride—Dizziness—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000475	CcSEcCtD
Amiloride—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000474	CcSEcCtD
Amiloride—Diarrhoea—Losartan—type 2 diabetes mellitus	4.51e-05	0.000463	CcSEcCtD
Amiloride—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000458	CcSEcCtD
Amiloride—Vomiting—Irbesartan—type 2 diabetes mellitus	4.45e-05	0.000457	CcSEcCtD
Amiloride—Rash—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000453	CcSEcCtD
Amiloride—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.41e-05	0.000453	CcSEcCtD
Amiloride—Nausea—Metformin—type 2 diabetes mellitus	4.41e-05	0.000452	CcSEcCtD
Amiloride—Headache—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.00045	CcSEcCtD
Amiloride—Dizziness—Losartan—type 2 diabetes mellitus	4.36e-05	0.000447	CcSEcCtD
Amiloride—Vomiting—Losartan—type 2 diabetes mellitus	4.19e-05	0.00043	CcSEcCtD
Amiloride—Nausea—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000427	CcSEcCtD
Amiloride—Rash—Losartan—type 2 diabetes mellitus	4.16e-05	0.000426	CcSEcCtD
Amiloride—Dermatitis—Losartan—type 2 diabetes mellitus	4.15e-05	0.000426	CcSEcCtD
Amiloride—Headache—Losartan—type 2 diabetes mellitus	4.13e-05	0.000424	CcSEcCtD
Amiloride—Asthenia—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000416	CcSEcCtD
Amiloride—Pruritus—Ramipril—type 2 diabetes mellitus	4e-05	0.00041	CcSEcCtD
Amiloride—Nausea—Losartan—type 2 diabetes mellitus	3.92e-05	0.000402	CcSEcCtD
Amiloride—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000397	CcSEcCtD
Amiloride—Dizziness—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000383	CcSEcCtD
Amiloride—Vomiting—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000369	CcSEcCtD
Amiloride—Rash—Ramipril—type 2 diabetes mellitus	3.56e-05	0.000366	CcSEcCtD
Amiloride—Dermatitis—Ramipril—type 2 diabetes mellitus	3.56e-05	0.000365	CcSEcCtD
Amiloride—Headache—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000363	CcSEcCtD
Amiloride—Nausea—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000344	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.21e-05	0.000165	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CD36—type 2 diabetes mellitus	1.21e-05	0.000165	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—GNB3—type 2 diabetes mellitus	1.2e-05	0.000164	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	1.2e-05	0.000164	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.19e-05	0.000163	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS2—type 2 diabetes mellitus	1.18e-05	0.000162	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TGFB1—type 2 diabetes mellitus	1.17e-05	0.00016	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.17e-05	0.00016	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.17e-05	0.000159	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BHMT—type 2 diabetes mellitus	1.16e-05	0.000159	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.16e-05	0.000159	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.14e-05	0.000156	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IRS1—type 2 diabetes mellitus	1.13e-05	0.000155	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.13e-05	0.000154	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	1.13e-05	0.000154	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARA—type 2 diabetes mellitus	1.12e-05	0.000153	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GNB3—type 2 diabetes mellitus	1.12e-05	0.000153	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	1.12e-05	0.000153	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.1e-05	0.00015	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AANAT—type 2 diabetes mellitus	1.09e-05	0.000149	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.09e-05	0.000149	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AGT—type 2 diabetes mellitus	1.09e-05	0.000149	CbGpPWpGaD
Amiloride—SLC9A1—Disease—INS—type 2 diabetes mellitus	1.09e-05	0.000148	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.08e-05	0.000148	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—ADCY5—type 2 diabetes mellitus	1.07e-05	0.000146	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CALM1—type 2 diabetes mellitus	1.07e-05	0.000146	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOE—type 2 diabetes mellitus	1.06e-05	0.000146	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOA1—type 2 diabetes mellitus	1.05e-05	0.000144	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	1.05e-05	0.000143	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT2—type 2 diabetes mellitus	1.05e-05	0.000143	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CDO1—type 2 diabetes mellitus	1.04e-05	0.000141	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPD2—type 2 diabetes mellitus	1.04e-05	0.000141	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.03e-05	0.000141	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGDS—type 2 diabetes mellitus	1.02e-05	0.000139	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AANAT—type 2 diabetes mellitus	1.02e-05	0.000139	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.01e-05	0.000138	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—type 2 diabetes mellitus	9.98e-06	0.000136	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—ADCY5—type 2 diabetes mellitus	9.96e-06	0.000136	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AK1—type 2 diabetes mellitus	9.88e-06	0.000135	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CDO1—type 2 diabetes mellitus	9.65e-06	0.000132	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPD2—type 2 diabetes mellitus	9.65e-06	0.000132	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	9.62e-06	0.000131	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	9.62e-06	0.000131	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3R1—type 2 diabetes mellitus	9.53e-06	0.00013	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS3—type 2 diabetes mellitus	9.53e-06	0.00013	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	9.39e-06	0.000128	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	9.39e-06	0.000128	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	9.34e-06	0.000128	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	9.28e-06	0.000127	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—type 2 diabetes mellitus	9.28e-06	0.000127	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AK1—type 2 diabetes mellitus	9.21e-06	0.000126	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—CALM1—type 2 diabetes mellitus	9.19e-06	0.000126	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MAT1A—type 2 diabetes mellitus	9.11e-06	0.000125	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A4—type 2 diabetes mellitus	9.11e-06	0.000125	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—INS—type 2 diabetes mellitus	9.1e-06	0.000124	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	8.97e-06	0.000123	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	8.97e-06	0.000123	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ND1—type 2 diabetes mellitus	8.8e-06	0.00012	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.8e-06	0.00012	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—G6PC—type 2 diabetes mellitus	8.8e-06	0.00012	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ENPP1—type 2 diabetes mellitus	8.8e-06	0.00012	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HBA2—type 2 diabetes mellitus	8.8e-06	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	8.75e-06	0.00012	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—type 2 diabetes mellitus	8.71e-06	0.000119	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	8.7e-06	0.000119	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	8.65e-06	0.000118	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—PRKCB—type 2 diabetes mellitus	8.63e-06	0.000118	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—CALM1—type 2 diabetes mellitus	8.56e-06	0.000117	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GCGR—type 2 diabetes mellitus	8.53e-06	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MAT1A—type 2 diabetes mellitus	8.5e-06	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A4—type 2 diabetes mellitus	8.5e-06	0.000116	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—type 2 diabetes mellitus	8.34e-06	0.000114	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—G6PC—type 2 diabetes mellitus	8.2e-06	0.000112	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HBA2—type 2 diabetes mellitus	8.2e-06	0.000112	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.2e-06	0.000112	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ENPP1—type 2 diabetes mellitus	8.2e-06	0.000112	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ND1—type 2 diabetes mellitus	8.2e-06	0.000112	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	8.18e-06	0.000112	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—type 2 diabetes mellitus	8.16e-06	0.000111	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.15e-06	0.000111	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYTB—type 2 diabetes mellitus	8.05e-06	0.00011	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—OXCT1—type 2 diabetes mellitus	8.05e-06	0.00011	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—PRKCB—type 2 diabetes mellitus	8.05e-06	0.00011	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.98e-06	0.000109	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—type 2 diabetes mellitus	7.98e-06	0.000109	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GCGR—type 2 diabetes mellitus	7.95e-06	0.000109	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SRD5A1—type 2 diabetes mellitus	7.85e-06	0.000107	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	7.8e-06	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	7.62e-06	0.000104	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	7.59e-06	0.000104	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYTB—type 2 diabetes mellitus	7.5e-06	0.000103	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—OXCT1—type 2 diabetes mellitus	7.5e-06	0.000103	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—STAR—type 2 diabetes mellitus	7.48e-06	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACACA—type 2 diabetes mellitus	7.48e-06	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD17B3—type 2 diabetes mellitus	7.48e-06	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	7.48e-06	0.000102	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SRD5A1—type 2 diabetes mellitus	7.31e-06	9.99e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—type 2 diabetes mellitus	7.3e-06	9.97e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	7.27e-06	9.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCC8—type 2 diabetes mellitus	7.18e-06	9.81e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CBS—type 2 diabetes mellitus	7.18e-06	9.81e-05	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	7.07e-06	9.66e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SRC—type 2 diabetes mellitus	7.05e-06	9.63e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACACA—type 2 diabetes mellitus	6.98e-06	9.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—STAR—type 2 diabetes mellitus	6.98e-06	9.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD17B3—type 2 diabetes mellitus	6.98e-06	9.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	6.97e-06	9.53e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—COX2—type 2 diabetes mellitus	6.91e-06	9.44e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A2—type 2 diabetes mellitus	6.91e-06	9.44e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NCOA6—type 2 diabetes mellitus	6.79e-06	9.27e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CBS—type 2 diabetes mellitus	6.69e-06	9.14e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCC8—type 2 diabetes mellitus	6.69e-06	9.14e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD11B1—type 2 diabetes mellitus	6.67e-06	9.12e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UCP2—type 2 diabetes mellitus	6.67e-06	9.12e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UCP3—type 2 diabetes mellitus	6.67e-06	9.12e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.45e-06	8.81e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—COX2—type 2 diabetes mellitus	6.44e-06	8.8e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A2—type 2 diabetes mellitus	6.44e-06	8.8e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.42e-06	8.77e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.36e-06	8.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NCOA6—type 2 diabetes mellitus	6.32e-06	8.64e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—type 2 diabetes mellitus	6.3e-06	8.61e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PCK1—type 2 diabetes mellitus	6.27e-06	8.57e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD11B1—type 2 diabetes mellitus	6.22e-06	8.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UCP2—type 2 diabetes mellitus	6.22e-06	8.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UCP3—type 2 diabetes mellitus	6.22e-06	8.5e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—type 2 diabetes mellitus	6.18e-06	8.44e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.15e-06	8.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.01e-06	8.21e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.98e-06	8.18e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.93e-06	8.1e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HK1—type 2 diabetes mellitus	5.87e-06	8.03e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PCK1—type 2 diabetes mellitus	5.85e-06	7.99e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.75e-06	7.85e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.73e-06	7.83e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LPA—type 2 diabetes mellitus	5.67e-06	7.75e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—KCNJ11—type 2 diabetes mellitus	5.67e-06	7.75e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD3B2—type 2 diabetes mellitus	5.67e-06	7.75e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GCKR—type 2 diabetes mellitus	5.67e-06	7.75e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HK1—type 2 diabetes mellitus	5.47e-06	7.48e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDOB—type 2 diabetes mellitus	5.44e-06	7.43e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.36e-06	7.32e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LPA—type 2 diabetes mellitus	5.29e-06	7.22e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD3B2—type 2 diabetes mellitus	5.29e-06	7.22e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GCKR—type 2 diabetes mellitus	5.29e-06	7.22e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—KCNJ11—type 2 diabetes mellitus	5.29e-06	7.22e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.19e-06	7.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDOB—type 2 diabetes mellitus	5.07e-06	6.93e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.06e-06	6.91e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.86e-06	6.65e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.83e-06	6.61e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—type 2 diabetes mellitus	4.75e-06	6.49e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.72e-06	6.45e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GLP1R—type 2 diabetes mellitus	4.71e-06	6.44e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.62e-06	6.32e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTR—type 2 diabetes mellitus	4.62e-06	6.32e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.53e-06	6.2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.53e-06	6.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HBA1—type 2 diabetes mellitus	4.51e-06	6.16e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LIPC—type 2 diabetes mellitus	4.51e-06	6.16e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GCK—type 2 diabetes mellitus	4.51e-06	6.16e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.48e-06	6.12e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A2—type 2 diabetes mellitus	4.4e-06	6.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.4e-06	6.01e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—type 2 diabetes mellitus	4.38e-06	5.98e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CETP—type 2 diabetes mellitus	4.35e-06	5.94e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CPT1A—type 2 diabetes mellitus	4.31e-06	5.89e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTR—type 2 diabetes mellitus	4.31e-06	5.89e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NAMPT—type 2 diabetes mellitus	4.23e-06	5.78e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HBA1—type 2 diabetes mellitus	4.2e-06	5.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LIPC—type 2 diabetes mellitus	4.2e-06	5.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GCK—type 2 diabetes mellitus	4.2e-06	5.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP11A1—type 2 diabetes mellitus	4.17e-06	5.7e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC9A1—type 2 diabetes mellitus	4.1e-06	5.6e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CETP—type 2 diabetes mellitus	4.05e-06	5.54e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.04e-06	5.52e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.04e-06	5.52e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.04e-06	5.52e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CTGF—type 2 diabetes mellitus	3.97e-06	5.42e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.93e-06	5.37e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.85e-06	5.27e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.85e-06	5.26e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PSMD6—type 2 diabetes mellitus	3.77e-06	5.15e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SNAP25—type 2 diabetes mellitus	3.77e-06	5.15e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SREBF1—type 2 diabetes mellitus	3.77e-06	5.15e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CTGF—type 2 diabetes mellitus	3.7e-06	5.05e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.7e-06	5.05e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—type 2 diabetes mellitus	3.67e-06	5.01e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMGCR—type 2 diabetes mellitus	3.66e-06	5.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1A2—type 2 diabetes mellitus	3.66e-06	4.99e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.66e-06	4.99e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.59e-06	4.91e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.59e-06	4.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.56e-06	4.87e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.5e-06	4.79e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	3.5e-06	4.79e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.45e-06	4.71e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.41e-06	4.66e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.41e-06	4.66e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.32e-06	4.54e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	3.27e-06	4.46e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.27e-06	4.46e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	3.02e-06	4.13e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.02e-06	4.13e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.01e-06	4.11e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	2.97e-06	4.05e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	2.88e-06	3.94e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	2.82e-06	3.85e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.82e-06	3.85e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.8e-06	3.83e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.8e-06	3.83e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	2.77e-06	3.78e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	2.75e-06	3.76e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.69e-06	3.68e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	2.68e-06	3.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	2.68e-06	3.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	2.61e-06	3.57e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.61e-06	3.57e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.58e-06	3.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	2.56e-06	3.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.51e-06	3.43e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	2.5e-06	3.42e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.48e-06	3.38e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	2.44e-06	3.33e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	2.43e-06	3.32e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.4e-06	3.29e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	2.35e-06	3.21e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	2.31e-06	3.16e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.31e-06	3.15e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	2.31e-06	3.15e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	2.28e-06	3.11e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	2.26e-06	3.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	2.19e-06	3e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-06	2.95e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	2.15e-06	2.94e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	2.12e-06	2.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	2.01e-06	2.74e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	1.97e-06	2.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	1.87e-06	2.56e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	2.51e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	1.81e-06	2.47e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	1.73e-06	2.36e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.73e-06	2.36e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	1.68e-06	2.3e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-06	2.2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-06	2.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.58e-06	2.16e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.47e-06	2.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	7.94e-07	1.08e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	7.4e-07	1.01e-05	CbGpPWpGaD
